The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%)...

|About: Celgene Corporation (CELG)|By:, SA News Editor

The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%) shareholders over whether the company made "potentially materially false and misleading" statements about its prospects and operations. The announcement cites the long run-up in Celgene's shares before they plunged following a regulatory setback for its Revlimid drug.